论文部分内容阅读
笔者将九一升白口服液用于经~(131)I 治疗的 Graves 病(GD)伴 WBC 减少患者29例,并与同期使用鲨肝醇、维生素B_4利血生片结合~(131)I 治疗的29例作对比,现报道如下。一、资料与方法选择本院 GD 伴 WBC 减少患者58例,其中男17例,女41例,中位年龄43.5(19～58)岁,病程1个月～9年,合并肝功能异常13例,恶性突眼7例。随机分为2组:治疗组29例,其中13例确诊后即发现 WBC 减少,未服用抗甲状腺药物(ATD),9例服用他巴唑、7例服用丙基硫氧嘧啶后出现外
Ninety-one liters of oral liquid was used in 29 patients with Graves’ disease (GD) accompanied by WBC reduction by 131I treatment and 131I (131I) combined with batyl alcohol and vitamin B 4 reserpine. Treatment of 29 cases for comparison, are reported below. First, the data and methods to choose our hospital GD with WBC reduce 58 patients, including 17 males and 41 females, the median age of 43.5 (19 to 58) years of age, duration of 1 month to 9 years, with liver dysfunction in 13 cases , Malignant exophthalmos in 7 cases. Randomly divided into two groups: treatment group of 29 cases, of which 13 cases were diagnosed after the discovery of WBC decreased, did not take anti-thyroid drugs (ATD), 9 cases taking methimazole, 7 cases after taking propylthiouracil